Milestone Pharmaceuticals Ownership | Who Owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals Ownership Summary

Milestone Pharmaceuticals is owned by 17.84% institutional investors, 3.37% insiders, and 78.79% retail investors. Blackrock is the largest institutional shareholder, holding 9.91% of MIST shares. Simplify Propel Opportunities ETF is the top mutual fund, with 3.33% of its assets in Milestone Pharmaceuticals shares.

MIST Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Milestone Pharmaceuticals	17.84%	3.37%	78.79%
Sector	Healthcare Stocks	487.91%	11.08%	-398.99%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	4.97M	9.91%	$6.56M
Simplify asset management	2.83M	4.27%	$5.67M
Millennium management	2.70M	4.08%	$6.38M
Rtw investments, lp	2.51M	3.78%	$4.86M
Propel bio management	1.79M	2.70%	$3.48M
Alta fundamental advisers	1.40M	2.11%	$2.71M
Bml capital management	1.14M	1.71%	$2.20M
Morgan stanley	828.65K	1.65%	$1.09M
Lion point capital, lp	1.03M	1.55%	$2.42M
Toronto dominion bank	750.00K	1.13%	$1.46M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Lion point capital, lp	1.03M	12.68%	$2.42M
Propel bio management	1.79M	4.22%	$3.48M
Bml capital management	1.14M	1.67%	$2.20M
Alta fundamental advisers	1.40M	1.39%	$2.71M
Bleichroeder lp	500.00K	0.24%	$970.00K
Simplify asset management	2.83M	0.10%	$5.67M
Rtw investments, lp	2.51M	0.07%	$4.86M
Stephenson & company	20.00K	0.02%	$40.00K
Boxer capital	309.01K	0.02%	$407.89K
Bay rivers group	16.69K	0.01%	$33.38K

Top Buyers

Holder	Shares	% Assets	Change
Simplify asset management	2.83M	0.10%	1.84M
Propel bio management	1.79M	4.22%	340.00K
Xtx topco	160.96K	0.01%	108.96K
Ubs group	89.51K	-	89.51K
Group one trading	52.64K	0.00%	52.64K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	-	-	-4.05M
Orbimed advisors	-	-	-2.00M
Nantahala capital management	-	-	-1.45M
Goldman sachs group	-	-	-942.41K
Velan capital investment management lp	-	-	-650.00K

New Positions

Holder	Shares	% Assets	Change	Value
Ubs group	89.51K	-	89.51K	$211.23K
Group one trading	52.64K	0.00%	52.64K	$124.22M
Colony group	36.00K	0.00%	36.00K	$69.84K
Susquehanna group, llp	33.09K	-	33.09K	$78.10K
Stephenson & company	20.00K	0.02%	20.00K	$40.00K

Sold Out

Holder	Change
Citigroup	-2.00
Qube research	-194.00
Ica group wealth management	-200.00
Royal bank of canada	-800.00
Jpmorgan chase	-3.27K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	49	4.26%	11,823,806	13.72%	17	7.25%	22	4.76%	9	-18.18%
Mar 31, 2025	48	-4.00%	11,814,084	-51.88%	17	1.30%	21	-12.50%	13	-7.14%
Dec 31, 2024	49	16.67%	24,552,980	-14.38%	37	1.98%	24	71.43%	14	75.00%
Sep 30, 2024	41	-	28,647,040	-5.08%	43	1.20%	13	-	8	33.33%
Jun 30, 2024	41	-6.82%	30,178,631	-3.74%	60	1.13%	13	-48.00%	6	20.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Simplify Propel Opportunities ETF	2.83M	3.33%	1.84M
Biotech Growth Ord	474.28K	0.89%	-333.41K
BlackRock Credit Strategies Instl	231.56K	0.43%	-29.79K
LUNIS Biotech Growth Opp Fd I a	26.90K	0.05%	-
WEALTHGATE Biotech Fund Inst	26.90K	0.05%	26.90K
SPDR® S&P® International Small Cap ETF	18.73K	0.02%	-
Fidelity Nasdaq Composite Index	17.96K	0.02%	-
Dimensional Global Core Equity USD Acc	5.87K	0.01%	-
Dimensional Global Small Coms USD Acc	5.02K	0.01%	5.00
Dimensional World Equity GBP Acc	3.65K	0.01%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 01, 2022	Bharucha David	Chief Medical Officer	Buy	$14.58K
Dec 05, 2022	Bharucha David	Chief Medical Officer	Buy	$32.83K
Oct 19, 2022	Wills Robert James	-	Buy	$73.95K
Oct 20, 2022	Pasternak Richard C	-	Buy	$52.00K
Oct 20, 2022	Liebert Debra K.	-	Buy	$52.90K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q3	-	-
2023 Q2	-	-
2023 Q1	-	-

MIST Ownership FAQ

Who Owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals shareholders are primarily institutional investors at 17.84%, followed by 3.37% insiders and 78.79% retail investors. The average institutional ownership in Milestone Pharmaceuticals's industry, Biotech Stocks , is 307.10%, which Milestone Pharmaceuticals falls below.

Who owns the most shares of Milestone Pharmaceuticals?

Milestone Pharmaceuticals’s largest shareholders are Blackrock (4.97M shares, 9.91%), Simplify asset management (2.83M shares, 4.27%), and Millennium management (2.7M shares, 4.08%). Together, they hold 18.26% of Milestone Pharmaceuticals’s total shares outstanding.

Does Blackrock own Milestone Pharmaceuticals?

Yes, BlackRock owns 9.91% of Milestone Pharmaceuticals, totaling 4.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.56M$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Milestone Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Lion point capital, lp is Milestone Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 12.68% of its assets in 1.03M Milestone Pharmaceuticals shares, valued at 2.42M$.

Who is the top mutual fund holder of Milestone Pharmaceuticals shares?

Simplify Propel Opportunities ETF is the top mutual fund holder of Milestone Pharmaceuticals shares, with 3.33% of its total shares outstanding invested in 2.83M Milestone Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools